MyMD Pharmaceuticals Inc (MYMD): There has been no shortage of info about...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	4
Posts	682
Boards Moderated	0
Alias Born	06/26/2013

knuts4oe

Re: SeanVan post# 109

Tuesday, 08/03/2021 8:28:08 PM

Tuesday, August 03, 2021 8:28:08 PM

There has been no shortage of info about the tremendous potential for MyMD.
What we are lacking is the SCIENCE to bring it into the real world!

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent MYMD News

Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 05/31/2024 12:00:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:05:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 01:10:03 PM
MyMD Pharmaceuticals Secures Strategic Investments • Business Wire • 05/21/2024 01:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 09:01:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:30:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 04:00:19 PM
MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing • Business Wire • 03/05/2024 02:15:00 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:13:35 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 04:27:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:57:03 PM
MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing • Business Wire • 02/13/2024 04:45:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 02:15:12 PM
MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis • Business Wire • 12/06/2023 02:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 01:00:10 PM
MyMD Announces Preclinical Study Results Showing Novel Cannabidiol Analog, Supera-CBD™, Reduced Acute Inflammatory Pain • Business Wire • 10/19/2023 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 09:00:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 08:30:23 PM
MyMD Pharmaceuticals to Present Updated Statistically Significant Phase 2 Data for MYMD-1, Potential TNF-α Market Disrupter, at BioFuture 2023 • Business Wire • 10/04/2023 11:30:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 09:24:39 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/24/2023 09:58:33 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/18/2023 08:21:49 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:00:57 PM

More MYMD News

InvestorsHub NewsWire

ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM

Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM

Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM

HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM

Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM

Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover